$RGBP SAN DIEGO, March 23, 2017 /PRNewswire/ -- Analogues Have Been Synthesized for Lead Compounds and are Complete, now the Optimization Process is set to Begin Utilizing NR2F6 Protein Molecules https://finance.yahoo.com/news/regen-biopharma-inc-provides-nr2f6-120000232.html